Technology Grant


Zucker Institute for Innovation Commercialization

IDEA Technology Grant

Sponsored by the Office of Innovation and the Zucker Institute for Innovation Commercialization, the IDEA Technology Grant provides $20,000 in Technology-based product advancement to support short-term (six month) projects designed to improve the translation potential of an innovation by moving it to the next developmental milestone(s), thus increasing the likelihood of partnerships, licensing, or implementation.
Example milestones for IDEA Technology Grant - include, but are not limited to:

  • Software program or mobile application development
  • Studies to validate software program or mobile application
  • Validation of a clinical or educational program with technology component (i.e. software as a service, novel tool such as checklist or kit)
  • Small efficacy pilot
  • Medical device development

Innovations relying on development of therapeutics, diagnostics, and cellular therapies are excluded from eligibility, as they are funded under the IDEA Therapeutics Grant RFA.
This RFA is open to advance innovations protected by, or protectable by, IP that is assigned or assignable to MUSC pursuant the MUSC IP Policy. If a patent or patent application is not currently assigned to the Zucker Institue, a Record of Invention or Disclosure of Copyrightable Work or Mobile Application must be on file with the Zucker Institute at least one month in advance of the application due date.
One award is anticipated to be funded each cycle.



The Application consists of five components:

  1. Each investigator’s CV
  2. Project Summary, 1-page limit
  3. Budget and Justification: PHS 398format
  4. Project Proposal, 5-page limit
  5. Letter(s) of Support


Applications will be reviewed by a panel including scientific/technical evaluators, members from an external review board, Office of Innovation leadership, and the Zucker Institute.


Dates for the FY24 grant will be available soon.